These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19542712)

  • 1. [Treatment of cancer of unknown primary, today and future].
    Shibata H
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):918-22. PubMed ID: 19542712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics of cancer of unknown primary (CUP)--a summary of 22 cases].
    Kato S; Yasuda K; Nishino Y; Ohori H; Takahashi M; Takahashi S; Yamaura G; Ohtsuka K; Kakudo Y; Chiba N; Shimodaira H; Sakayori M; Kato S; Suzuki T; Murakawa Y; Gamoh M; Shibata H; Yoshioka T; Ishioka C
    Gan To Kagaku Ryoho; 2007 Aug; 34(8):1227-31. PubMed ID: 17687203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2009 Mar; 69(3):271-8. PubMed ID: 18977667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supraclavicular lymph node metastases of unknown origin: HPV-typing identifies the primary tumour.
    Kuemper C; Burges A; Hillemanns P; Mueller-Egloff S; Lenhard M; Ditsch N; Strauss A
    Eur J Cancer Care (Engl); 2009 Nov; 18(6):606-11. PubMed ID: 19549285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Switching benchmarks in cancer of unknown primary: from autopsy to microarray.
    Pentheroudakis G; Golfinopoulos V; Pavlidis N
    Eur J Cancer; 2007 Sep; 43(14):2026-36. PubMed ID: 17698346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Unknown primary tumour--diagnostic strategies and treatment].
    Møller AK; Gundgaard MG; Petersen BL; Daugaard G
    Ugeskr Laeger; 2008 Nov; 170(48):3946-9. PubMed ID: 19087733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of unknown primary (CUP); some considerations about pathogenesis and diagnostic strategy, particularly focusing on CUPS pertaining to the Urology.
    Alberti C
    G Chir; 2012; 33(1-2):41-6. PubMed ID: 22357439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unknown primary cancer].
    Furue H
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):1-6. PubMed ID: 9464322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cancer of unknown primary site-current status and future direction].
    Ichikawa Y; Okamoto I; Nakagawa K
    Gan To Kagaku Ryoho; 2009 Jun; 36(6):907-9. PubMed ID: 19542709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic carcinoma of unknown origin].
    Fizazi K; Culine S
    Bull Cancer; 1998 Jul; 85(7):609-17. PubMed ID: 9752267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of clinical practice guidelines on the management for carcinomas of unknown primary site: a controlled "before-after" study.
    Sève P; Mackey J; Sawyer M; Lesimple T; de La Fouchardière C; Broussolle C; Dumontet C; Ray-Coquard I
    Bull Cancer; 2009 Apr; 96(4):E7-17. PubMed ID: 19435692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Limit investigation in cancer of unknown primary site].
    Berglund A; Nygren P; Hagberg H; Påhlman L; Sundin A; Sundström C
    Lakartidningen; 2005 Oct 10-16; 102(41):2946-8, 2950-2. PubMed ID: 16294513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer of unknown primary site: missing primary or missing biology?
    Pentheroudakis G; Briasoulis E; Pavlidis N
    Oncologist; 2007 Apr; 12(4):418-25. PubMed ID: 17470684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [CUP syndrome: are there advances?].
    Moll R
    Verh Dtsch Ges Pathol; 2005; 89():125-36. PubMed ID: 18035682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative survival with diverse chemotherapy regimens for cancer of unknown primary site: multiple-treatments meta-analysis.
    Golfinopoulos V; Pentheroudakis G; Salanti G; Nearchou AD; Ioannidis JP; Pavlidis N
    Cancer Treat Rev; 2009 Nov; 35(7):570-3. PubMed ID: 19539430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of "unfavourable" carcinoma of unknown primary site: synthesis of recent literature.
    Amela EY; Lauridant-Philippin G; Cousin S; Ryckewaert T; Adenis A; Penel N
    Crit Rev Oncol Hematol; 2012 Nov; 84(2):213-23. PubMed ID: 22503530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer of unknown primary origin: a decade of experience in a community-based hospital.
    Pimiento JM; Teso D; Malkan A; Dudrick SJ; Palesty JA
    Am J Surg; 2007 Dec; 194(6):833-7; discussion 837-8. PubMed ID: 18005780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling to identify the histogenetic origin of metastatic adenocarcinomas of unknown primary.
    Horlings HM; van Laar RK; Kerst JM; Helgason HH; Wesseling J; van der Hoeven JJ; Warmoes MO; Floore A; Witteveen A; Lahti-Domenici J; Glas AM; Van't Veer LJ; de Jong D
    J Clin Oncol; 2008 Sep; 26(27):4435-41. PubMed ID: 18802156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer of unknown primary (CUP).
    Pavlidis N; Fizazi K
    Crit Rev Oncol Hematol; 2005 Jun; 54(3):243-50. PubMed ID: 15890271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer of unknown primary site.
    Schlag PM; Hünerbein M
    Ann Chir Gynaecol; 1994; 83(1):8-12. PubMed ID: 8053645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.